
    
      Hemodialysis patients who have residual kidney function will undergo two 4-week study (twice
      weekly versus thrice weekly hemodialysis). Blood, urine, and dialysate samples will be
      collected at the end of each study period to determine adequacy of treatment and to assess
      uremic solute levels. Participants will complete quality of life questionnaires and cognitive
      paper tests. Food records and medications may be monitored.
    
  